Abstract
A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Graphical Abstract
Current Bioinformatics
Title:Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost
Volume: 11 Issue: 1
Author(s): Can Zhang, Xueyuan Wang, Lei Gu, Li Jiang, Qiang Su, Manman Zhao, Linfeng Zheng, Ling Tang, Fuxue Chen and Bing Niu
Affiliation:
Keywords: Molecular descriptors, acetylcholinesterase, bakuchiol, Adaboost.
Abstract: A structure-activity relationship (SAR) dataset was generated for a set of acetylcholinesterase inhibitors using Adaboost and physicochemical parameters. After calculation, it is found that the ACC of SAR model is 99.51 by using 10-fold cross-validation test, while 99.35% for independent test set. Based on the SAR prediction model, bakuchiol is predicted to be an acetylcholinesterase inhibitor. Fluorescence was used to investigate the binding between bakuchiol and acetylcholinesterase, which can provide valuable qualitative and quantitative information about the interaction between acetylcholinesterase and bakuchiol.
Export Options
About this article
Cite this article as:
Zhang Can, Wang Xueyuan, Gu Lei, Jiang Li, Su Qiang, Zhao Manman, Zheng Linfeng, Tang Ling, Chen Fuxue and Niu Bing, Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost, Current Bioinformatics 2016; 11 (1) . https://dx.doi.org/10.2174/1574893611666151119220248
DOI https://dx.doi.org/10.2174/1574893611666151119220248 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemistry and Biological Activities of 1,3-Benzoxathiol-2-ones
Mini-Reviews in Organic Chemistry Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders
Current Molecular Medicine Conventional (Continuous) EEG Monitoring in the NICU
Current Pediatric Reviews Engineering of Conotoxins for the Treatment of Pain
Current Pharmaceutical Design Relationship Between Polymerase Gamma (POLG) Polymorphisms and Antiretroviral Therapy-Induced Lipodystrophy in HIV-1 Infected Patients: A Case-Control Study
Current HIV Research The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders
Current Topics in Medicinal Chemistry Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Current Psychiatry Reviews Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions
Recent Patents on Biomarkers Blood-brain Barrier Drug Discovery for Central Nervous System Infections
Current Drug Targets - Infectious Disorders Treatment-resistant Late-life Depression: Challenges and Perspectives
Current Neuropharmacology Analysis of NCL Proteins from an Evolutionary Standpoint
Current Genomics Acne in the Adult
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design 3D QSAR Studies on 1, 3, 4-Thiadiazole Derivatives: An Approach to Design Novel Anticonvulsants
Medicinal Chemistry Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis
Current Drug Targets Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
Current Pharmaceutical Biotechnology Determination of the Percent Composition and Mineral Content of the Leaves of the Insulin Plant (Cissus sicyoides) with the Goal of Including it in the Usual Diet
The Natural Products Journal Port-a-Patch and Patchliner: High Fidelity Electrophysiology for Secondary Screening and Safety Pharmacology
Combinatorial Chemistry & High Throughput Screening